Abstract
Differential diagnosis between radiation necrosis and tumour recurrence is important in the clinical manage- ment of patients with glioma. We performed an overview of the literature in order to summarize the role of 11 C- methionine positron emission tomography (MET-PET) in this setting. This functional imaging method appears to have a high sensitivity, specificity, and accuracy in differentiating between glioma recurrence and radiation necrosis. Neverthe- less, possible false negative and false positive results of MET-PET should be well kept in mind in the management of pa- tients with glioma.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
